BANGALORE, India--(BUSINESS WIRE)--Recognized for Commitment to Quality, Excellence, Leadership, Technology and Innovation, Estima Pharma Solutions LLP, India, was presented the CQE Century International Quality ERA Award, for compliance on QC 100 TQM (Total Quality Management) model criteria for 2015. Dr. Gurudatta G.G, Director & CEO, received this prestigious award from the President of Business Initiative Directions (BID) Group, Mr. Jose E. Prieto, at the InterContinental Geneva Convention Hall, Geneva, Switzerland on March 22nd 2015.
Companies and organizations from 54 countries around the world participated in the event, while Estima Pharma Solutions LLP was elected and recognized one among Indian Conglomerates and historic group of winners such as TATA ELXSI, IOCL, Reliance Infrastructure Ltd., Infra Support Engineering Consultants (P) Ltd., ICICI Bank Ltd., NCR Corporation India (P) Ltd., NTPC Ltd. in respective field of achievements and honorary member of the CQE council.
Pioneers in implementing a comprehensive method and tools on TQM since 1986, BID in collaboration with business peers in US and Europe organize annual conventions widely in Europe and US. Companies are identified and invited for remarkable achievements and outstanding commitment in this field, respectively.
Estima Pharma Solutions LLP, with Headquarters in Bangalore, India and incumbent human expertise comprising of Management Graduates, Pharmacists, Masters of Science of over 250 years of combined experience, has exponentially established as preferred GxP partner offering Total Pharma Business Solutions in conformity to International Regulatory Standards like EUGMP, USFDFA, UKMHRA, WHO, with their areas of expertise for establishment and implementation of Quality Management Systems comprehensively. Accreditations include obtaining 34 International Regulatory Approvals globally for their clients to date.
With an achieved export revenue of INR 2.70 Crore (USD 0.5 Million) its credit and EBIDTA of 25% in 2013-14 in the first year of operations and INR 10.00 Crore (USD 1.64 Million) EBIDTA of 45% in 2014-15, Estima Pharma Solutions LLP has phenomenally established base in South Korea, Vietnam and strengthen further in other South East Asian regions. Categorically the company has been instrumental for infusing Commerce and foreign revenue into India till date with formidable and exponential outlay of USD 50 Million by 2020 for Consultancy including R&D, Formulation Development Activity with incremental human capital, resource and infrastructure management.
Visit us at www.estimapharma.com.
